Home/Pipeline/3D Insert Scaffolds

3D Insert Scaffolds

Drug discovery & disease modeling

CommercialActive

Key Facts

Indication
Drug discovery & disease modeling
Phase
Commercial
Status
Active
Company

About 3D Biotek

Founded in 2004 (incorporated 2007), 3D Biotek is a private, revenue-generating company focused on advanced 3D cell culture technologies. Its product portfolio includes the 3D Insert scaffolds and the 3D Cell Expansion System (3D-CES), targeting the research tools and contract services markets. The company's value proposition centers on providing more physiologically relevant in vitro models to improve drug screening efficiency and enable large-scale cell expansion for therapeutic applications.

View full company profile

Other Drug discovery & disease modeling Drugs

DrugCompanyPhase
ORGANOID ModelsVital3D TechnologiesPre-clinical